Nearly 50 candidates in development.
16 approved medicines developed in-house.
One relentless scientific mission.
Press releases for investors and media
Stay current on Regeneron news and company updates
Press releases
Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026
Read moreRegeneron Announces Investor Conference Presentations
Read morePasatru™ (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions ...
Read moreThe Science of Chronic Itch & Inflammation
Discover how type 2 inflammation drives chronic itch in eczema, CSU, and skin diseases
Learn moreA Future Focused on Quality of Weight Loss
Regeneron leaders share their vision for the future of obesity treatment
Learn moreReducing COPD’s Global Impact on Lung Health
See why lung health belongs at the center of the healthy aging conversation
Learn moreThe Power of Proof in Modern Science
Connor Hill, top winner of Regeneron Science Talent Search 2026, shows how math thinking helps solve complex scientific challenges
Read the storyFrom biologics to genetic medicines, our journey turns
cutting-edge science into transformative medicine,
redefining excellence and efficiency in research and development.
We're guided by our philosophy of
doing well by doing good
We’re dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations. Our responsibility strategy addresses the issues that matter most to our business and our stakeholders — because we understand that our actions have a profound impact on the world around us.
Careers at Regeneron
Join the brightest, most passionate innovators in science. Find your next opportunity by applying for jobs and internships at Regeneron today.
Our clinical trials
Our journey of discovery continues as we strive to transform the lives of people with serious diseases. Discover more about our clinical trials or locate a relevant trial near you.